HDAC9 and B-cell chronic lymphocytic leukemia: This is consistent with the fact that HDAC inhibition has previously been reported to induce cell death by various molecular mechanisms, activating both the extrinsic and intrinsic pathways.23 Apart from its direct apoptotic effects, our results demonstrate that CUDC‐907 may also have an impact on survival pathways normally activated in CLL cells.